Development and Validation of a Therapeutic Decision Aid in Ectopic Pregnancy: GEUDECID Study (GEUDECID)
To Validate a Decision Aid for Ectopic Pregnancy
About this trial
This is an interventional other trial for To Validate a Decision Aid for Ectopic Pregnancy focused on measuring decision aid, shared decision making, less active ectopic pregnancy, methotrexate, medical treatment, surgery
Eligibility Criteria
Inclusion Criteria: Women who speak and read french Not opposed to participate to the research With a tubal ectopic pregnancy visible at sonography with an HCG rate under 10 000UI/ml Exclusion Criteria: Cardiac activity present in the embryo Hemoperitoin Hemodynamic instability Spontaneous pelvic pain Contre indication to methotrexate Protected adult patient
Sites / Locations
Arms of the Study
Arm 1
Experimental
Women with a less active ectopic pregnancy using a therapeutic decision tool for treatment decision
Women will have a therapeutic decision tool to help medical decision making and women and doctors will have to fill a questionnaire about the tool and the decision made